Jan Endell
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Genetics top 10%
- Virus-based gene therapy research
Papers in
- Oncology 13
- CAR-T cell therapy research 7
- Peptidase Inhibition and Analysis 5
-
- Monoclonal and Polyclonal Antibodies Research 8
- Co-authors
- Rainer Boxhammer (13 shared papers)Michael Hallek (3 shared papers)Luca Perabò (3 shared papers)Hildegard Büning (3 shared papers)Stefan Steidl (7 shared papers)Susan King (1 shared paper)David M. Kofler (1 shared paper)Kristin Leike (1 shared paper)
- Journals
- Blood (10 papers)Journal of Clinical Oncology (4 papers)Journal of Virology (2 papers)The Journal of Gene Medicine (1 paper)Oncotarget (1 paper)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Jan Endell
23 papers receiving 657 citations
Peers
Comparison fields: 5 of 57
- Hematology 132
- Genetics 290
- Oncology 226
- Physiology 33
- Molecular Biology 362
Countries citing papers authored by Jan Endell
This map shows the geographic impact of Jan Endell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Endell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Endell more than expected).
Fields of papers citing papers by Jan Endell
This network shows the impact of papers produced by Jan Endell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Endell. The network helps show where Jan Endell may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Endell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 113 | |
| 2 | 2005 | 106 | |
| 3 | 2006 | 104 | |
| 4 | 2010 | 60 | |
| 5 | 2014 | 38 | |
| 6 | 2019 | 35 | |
| 7 | 2016 | 32 | |
| 8 | 2012 | 31 | |
| 9 | 2015 | 24 | |
| 10 | 2015 | 20 | |
| 11 | 2016 | 16 | |
| 12 | 2009 | 11 | |
| 13 | 2022 | 9 | |
| 14 | 2019 | 9 | |
| 15 | 2011 | 9 | |
| 16 | 2012 | 8 | |
| 17 | 2014 | 8 | |
| 18 | 2019 | 8 | |
| 19 | 2019 | 8 | |
| 20 | 2020 | 7 |
About Jan Endell
Jan Endell is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Genetics, Hematology and Molecular Biology, having authored 23 papers that have together received 666 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Multiple Myeloma Research and Treatments (8 papers), CAR-T cell therapy research (7 papers), Peptidase Inhibition and Analysis (5 papers), Immune Cell Function and Interaction (4 papers), Synthesis and Biological Evaluation (3 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Hematology (132 citations), Genetics (290 citations), Oncology (226 citations), Physiology (33 citations) and Molecular Biology (362 citations). Jan Endell has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Rainer Boxhammer, Michael Hallek, Luca Perabò, Hildegard Büning, Stefan Steidl, Susan King, David M. Kofler, Kristin Leike, Stefan Finke and Grzegorz S. Nowakowski. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of Virology, The Journal of Gene Medicine and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.